Description
Chartreusinisanantibioticcompoundthatalsoexhibitsanticanceractivity.ChartreusinbindsGC-richDNAsequences,inhibitingsynthesisofRNAandcausingfreerADIcalaccumulation.
Chartreusinisanantibioticcompoundthatalsoexhibitsanticanceractivity.ChartreusinbindsGC-richDNAsequences,inhibitingsynthesisofRNAandcausingfreerADIcalaccumulation.
CasNo. | 6377-18-0 |
---|---|
Purity | ≥98% |
Formula | C32H32O14 |
FormulaWt. | 640.6 |
ChemicalName | Benzo(h)(1)benzopyrano(5,4,3-cde)(1)benzopyran-5,12-dione,10-((6-deoxy-2-O-(6-deoxy-3-O-methyl-alpha-D-galactopyranosyl)-beta-D-galactopyranosyl)oxy)-6-hydroxy-1-methyl-(9CI) |
Synonym | LamBDamycin;NSC-5159. |
MeltingPoint | 184-186°C |
Solubility | Solubleinacetone.Practicallyinsolubleinwater. |
Appearance | Yellowsold |
StoreTemp | -20°C |
---|---|
ShipTemp | BlueIce |
MSDS | C2803MSDSPDF |
---|---|
InfoSheet | C2803InfoSheetPDF |
PortugalJ.Chartreusin,elsamicinAandrelatedanti-cancerantibiotics.CurrMedChemAnticancerAgents.2003Nov;3(6):411-20.PMID:14529449.
UramotoM,KusanoT,NishioT,etal.Specificbindingofchartreusin,anantitumorantibiotic,toDNA.FEBSLett.1983Mar21;153(2):325-8.PMID:6311618.
YagiM,NishimuraT,SuzukiH,etal.Chartreusin,anantitumorglycosideantibiotic,inducesDNAstrandscission.BiochemBiophysResCommun.1981Feb12;98(3):642-7.PMID:7225117.